UPyTher, a spin-off company of the Eindhoven University of Technology, is a preclinical stage company and develops long-acting hydrogel-drug formulations for the treatment of peritoneal diseases – a field that comes with specific requirements when it comes to local intraperitoneal drug delivery and treatment.
The company was founded in 2020 with the vision to increase the treatment options and outcome for patients with peritoneal carcinomatosis and turn it into a treatable disease. Our mission is to set a new standard of care in peritoneal oncology by making intraperitoneal therapy simple, safe, and effective.
Company Details
- Employees
- 5
- Founded
- 2020
- Address
- Eindhoven, Nl
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.upyther.com
- HQ
- Eindhoven
Upyther Questions
Upyther's website is http://www.upyther.com
Upyther's LinkedIn profile is https://nl.linkedin.com/company/upyther
Upyther has
5 employees.
View email and phone details for 5
employees at Upyther.
Upyther's industry is
Biotechnology Research
Upyther's top competitors are
3d Medical Support Bv,
Nc Biomatrix B.v.,
Biovaxys Technology Corp.,
Sata Medical,
Vivart-X,
Vzarii Therapeutics,
Edf International,
Scope Biosciences B.v.,
Novya Biotech,
Nanoworx.
Upyther's categories are Biotechnology Research
Upyther's founding year is 2020
